Clinical Trial Update: A Study to Desensitize Allergic Reactions to Treatments for Blood Disorders [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on desensitization for allergic reactions to treatments used for blood disorders, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyloidosis
• Multiple Myeloma

Snippet

Sponsor: University Health Network, Toronto | Conditions: Multiple Myeloma, Amyloidosis | Phase 2 | Status: COMPLETED